Tianjin Ringpu Bio-Technology Co.,Ltd. Stock

Stocks

300119

CNE100000TV1

Pharmaceuticals

End-of-day quote Shenzhen S.E. 2026-08-06 5-day change 1st Jan Change
18.05 CNY -0.33% Intraday chart for Tianjin Ringpu Bio-Technology Co.,Ltd. +7.89% -3.84%

Valuation: Tianjin Ringpu Bio-Technology Co.,Ltd.

Market Cap 8.2B 1.21B 1.05B 986M 902M 1.7B 116B 1.73B 11.54B 4.53B 57.78B 4.56B 4.46B 192B P/E 2026 *
18.8x
P/E 2027 * 16.5x
Enterprise Value 8.72B 1.29B 1.12B 1.05B 960M 1.81B 123B 1.84B 12.27B 4.82B 61.44B 4.85B 4.74B 204B EV / Sales 2026 *
2.32x
EV / Sales 2027 * 2.02x
Free-Float
51.96%
Yield 2026 *
1.66%
Yield 2027 * 2.68%
06-09 Tianjin Ringpu Bio-Technology Co.,Ltd. signed an Equity Transfer Agreement to acquire an additional 30% stake in Tianjin Zhongrui Supply Chain Management Co., Ltd. from Ringpai National Chain Veterinary Hospital Management Co., Ltd. for CNY 65.9 million. CI
04-27 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
03-30 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
03-29 Tianjin Ringpu Bio-Technology Co.,Ltd. announces Annual dividend, payable on May 13, 2026 CI
03-26 Tianjin Ringpu Bio-Technology Co.,Ltd. announced that it expects to receive CNY 300 million in funding CI
11-27 Ringpu Bio-Technology Secures Registration For Feline Vaccine MT
25-10-29 Maxhealth Biotech Co. Ltd. announced that it has received CNY 400 million in funding from IDG Ventures, Shenzhen Capital Group Co., Ltd., Tianjin Ringpu Bio-Technology Co.,Ltd. CI
25-10-24 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
25-08-25 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025 CI
25-07-14 Ringpu Bio-Tech Forecasts Up to 70% Rise in H1 Profit MT
25-06-13 Jiangxi Twins Biotechnology Co., Ltd signed a letter of intent to acquire 67.18% stake in Hunan Sinoland Bio-Pharmacy Co., Ltd. from Tianjin Ringpu Bio-Technology Co.,Ltd. and Jingpeng Holding Group Co., Ltd for approximately CNY 115 million. CI
25-04-30 Tranche Update on Tianjin Ringpu Bio-Technology Co.,Ltd.'s Equity Buyback Plan announced on November 4, 2024. CI
25-04-29 Tianjin Ringpu Bio-Technology Co.,Ltd.'s Equity Buyback announced on November 4, 2024, has closed with 6,997,751 shares, representing 1.52% for CNY 129.98 million. CI
1 day-0.33%
1 week+7.89%
Current month+6.05%
1 month+12.88%
3 months+1.01%
6 months-5.89%
Current year-3.84%
1 week 16.8
Extreme 16.8
18.71
1 month 15.21
Extreme 15.21
18.71
Current year 13.91
Extreme 13.91
21.51
1 year 13.91
Extreme 13.91
24.03
3 years 11.25
Extreme 11.25
28.9
5 years 11.25
Extreme 11.25
28.9
10 years 6.3
Extreme 6.3
44.41
Manager TitleAgeSince
Chief Executive Officer 53 2023-03-29
Director of Finance/CFO 51 2022-04-27
Corporate Officer/Principal 45 2020-10-26
Director TitleAgeSince
Chairman 63 2008-05-11
Director/Board Member 53 2019-12-24
Director/Board Member 51 2020-01-09
Date Insider Type Main position Quantity % Market Cap.
5/24/23 Buy 3,000 0.0009%
5/23/23 Buy 1,000 0.0003%
9/4/20 Sell

Chief Executive Officer

47,300 0.0193%
Change 5-day change 1-year change 3-year change Capi.($)
-0.33%+7.89%-16.32%-3.22% 1.21B
+3.87%+1.63%-47.26%-56.74% 32.39B
-7.70%-8.54%+73.48%+107.73% 12.09B
+2.84%+3.70%-13.36%+3.95% 3.96B
0.00%+1.78%+3.62%+22.24% 3.32B
-0.83%+11.69%+48.75%+28.33% 2.12B
+1.79%+4.56%+9.59%+29.74% 1.94B
-1.42%-2.61%+34.01%+133.40% 1.44B
+0.31%+1.24%-14.06%-46.13% 989M
+2.95%+0.55%-2.39%-21.08% 955M
Average -0.16%+0.31%+7.61%+19.82% 6.04B
Weighted average by Cap. -0.94%-0.40%-9.08%-3.41%

Financials

2026 *2027 *
Net sales 3.75B 556M 482M 451M 413M 780M 52.92B 790M 5.28B 2.07B 26.44B 2.09B 2.04B 88.01B 4.22B 625M 542M 508M 465M 877M 59.53B 888M 5.94B 2.33B 29.74B 2.35B 2.3B 98.99B
Net income 427M 63.2M 54.85M 51.36M 46.98M 88.69M 6.02B 89.85M 601M 236M 3.01B 237M 232M 10.01B 508M 75.22M 65.27M 61.12M 55.91M 106M 7.17B 107M 715M 281M 3.58B 282M 276M 11.92B
Net Debt 519M 76.93M 66.76M 62.51M 57.18M 108M 7.33B 109M 731M 287M 3.66B 289M 283M 12.19B 337M 49.91M 43.32M 40.56M 37.1M 70.04M 4.75B 70.96M 475M 186M 2.38B 187M 183M 7.91B
Logo Tianjin Ringpu Bio-Technology Co.,Ltd.
Tianjin Ringpu Bio-Technology Co Ltd is a China-based company serving the animal health industry. The Company's main business areas are the research and development, production and sales of veterinary biological products, veterinary pharmaceutical preparations (chemicals, traditional Chinese veterinary medicines, disinfectants, and others), veterinary raw materials, veterinary functional additives, and provision of overall prevention and control of animal diseases. The Company's products include pharmaceuticals, vaccines, disinfectants, cleaning agents, and functional additives for pigs, chickens, waterfowl, cattle, sheep and pets, and others.
Employees
2,803
Date Price Change Volume
26-08-06 CN¥18.05 -0.33% 7,147,357
26-08-05 CN¥18.11 +2.43% 8,512,982
26-08-04 CN¥17.68 +2.67% 8,340,306
26-08-03 CN¥17.22 +1.18% 5,302,094
26-07-31 CN¥17.02 +1.73% 7,088,800
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
18.05CNY
Average target price
20.41CNY
Spread / Average Target
+13.07%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 300119 Stock